T1	PROC 47 104	Ensayo en fase III, aleatorizado, abierto y multicéntrico
T2	CHEM 108 120	domvanalimab
T3	CHEM 122 134	zimberelimab
T4	PROC 137 150	quimioterapia
#1	AnnotatorNotes T4	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure | C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T5	CHEM 170 179	nivolumab
#2	AnnotatorNotes T5	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T6	PROC 182 195	quimioterapia
#3	AnnotatorNotes T6	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure | C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T7	LIVB 199 212	participantes
T9	DISO 296 307	metastásico
#4	AnnotatorNotes T9	C4255448; Metastasis; Pathologic Function
T10	Neg_cue 332 334	no
T11	PROC 343 350	tratado
T12	Negated 343 350	tratado
T13	DISO 388 409	Esofágico metastásico
T14	DISO 412 427	Cáncer Gástrico
#5	AnnotatorNotes T14	C0024623; Malignant neoplasm of stomach; Neoplastic Process
T15	LIVB 456 469	Participantes
T16	PROC 474 485	diagnóstico
#6	AnnotatorNotes T16	C0011900; Diagnosis; Diagnostic Procedure
T17	PROC 497 513	histológicamente
T18	DISO 517 563	adenocarcinoma gástrico, esofágico o de la UGE
T19	DISO 578 589	metastásico
#7	AnnotatorNotes T19	C4255448; Metastasis; Pathologic Function
T20	PROC 613 629	Estado funcional
T21	DISO 723 729	lesión
#8	AnnotatorNotes T21	C0221198; Lesion; Finding | C3263723; Traumatic injury; Injury or Poisoning
T24	ANAT 884 891	órganos
#11	AnnotatorNotes T24	C0178784; Organ; Body Part, Organ, or Organ Component | C1280836; Entire body organ; Body Part, Organ, or Organ Component
T25	ANAT 897 908	médula ósea
#12	AnnotatorNotes T25	C0005953; Bone Marrow; Tissue
T26	ANAT 944 959	muestra tumoral
T27	DISO 990 996	cáncer
#13	AnnotatorNotes T27	C0006826; Malignant Neoplasms; Neoplastic Process
T28	CHEM 1054 1107	ligando 1 de la proteína de muerte celular programada
T29	CHEM 1109 1114	PD-L1
#14	AnnotatorNotes T29	C0965245; CD274 protein, human; Amino Acid, Peptide, or Protein · Immunologic Factor
T30	DISO 1144 1162	Afecciones médicas
T31	DISO 1165 1189	trastornos psiquiátricos
#15	AnnotatorNotes T31	C0004936; Mental disorders; Mental or Behavioral Dysfunction
T32	LIVB 1222 1234	investigador
#16	AnnotatorNotes T32	C0035173; Research Personnel; Professional or Occupational Group
T33	PROC 1264 1294	administración del tratamiento
T36	DISO 1349 1354	tumor
#17	AnnotatorNotes T36	C0027651; Neoplasms; Neoplastic Process | C0038999; Swelling; Finding
T37	PROC 1369 1373	HER2
T38	DISO 1391 1461	metástasis en el sistema nervioso central (SNC o cerebro) sintomáticas
T39	Neg_cue 1463 1466	sin
T40	PROC 1467 1473	tratar
T41	Negated 1467 1473	tratar
T42	PROC 1513 1534	tratamiento sistémico
T43	DISO 1550 1596	adenocarcinoma gástrico, esofágico o de la UGE
T44	DISO 1611 1622	metastásico
#18	AnnotatorNotes T44	C4255448; Metastasis; Pathologic Function
T45	CHEM 1653 1680	vacunas con microbios vivos
T46	Duration 1684 1695	los 28 días
T47	PROC 1709 1723	aleatorización
#19	AnnotatorNotes T47	C0034656; Randomization; Research Activity
T50	PROC 837 843	RECIST
T22	PROC 764 822	Criterios de evaluación de la respuesta en tumores sólidos
T51	PROC 1033 1041	análisis
T52	LIVB 1241 1249	promotor
T34	Contraindicated 1264 1294	administración del tratamiento
T8	DISO 217 281	adenocarcinoma gástrico, de la unión gastroesofágica y esofágico
T23	Route 1525 1534	sistémico
